In this episode of the PCRS Podcast our Executive Chair, Dr Katherine Hickman, is joined by Dr Llinos Jones, Consultant Respiratory Physician with a specialist interest in asthma.

Antibiotics are crucial for managing infectious diseases and preventing complications like pneumonia or sepsis. However, antimicrobial resistance (AMR) poses a growing global health threat, contributing to over 3 million deaths annually.

Are you curious about how research can fit into your everyday clinical practice?

Join Frances Barrett (Respiratory Nurse Specialist and PCRS Service Development Committee Member) and Darush Attar-Zadeh (Clinical Fellow Pharmacist and PCRS Executive Committee Member) as they dive into the incredibly important topic of Tobacco Dependency.

2024 marked a pivotal change in the management of asthma in the UK with the publication of a joint British Thoracic Society (BTS), National Institute for Health and Care Excellence (NICE) and Scottish Intercollegiate Guidelines Network (SIGN) guideline.

The Primary Care Respiratory Society (PCRS) believe that by working together we can achieve more environmentally friendly respiratory healthcare.

Over the past 20-years, there has been an increased focus on the use of newer biologic medication in people with severe asthma that is not controlled with usual asthma medication.

Joining Dr Daryl Freeman (PCRS Executive Committee Member, Associate Clinical Director with Norfolk Community Health and Care, and Respiratory ICB Lead for Norfolk and Waveney) on this episode of the PCRS Podcast is Professor Mike Crooks (Professor of Respiratory Medicine at Hull York Medical Sch

As healthcare professionals, we face the dual challenge of providing high-quality care while also minimising our environmental footprint.

The start of a new year is an ideal time to support people to consider small ways to begin working towards a healthy lifestyle.

In this podcast Dr Fiona Mosgrove (PCRS Education Committee member, GP with special interest in respiratory medicine) is joined by Professor James Chalmers (Asthma and Lung UK Chair of Respiratory Research) to talk about bronchiectasis and in particular the new treatments that are available for t

The environment and air quality has a considerable impact on people with respiratory conditions and the symptoms they experience. In turn, respiratory conditions, and the medication which treats them, adds considerably to the NHS carbon footprint.

The UK has the largest market for vapes in Western Europe.

The NHS is under increased financial and environmental pressures. Blanket switching of medications (changing medication from one to another without patient consultation) to more cost-effective and environmentally friendly options is therefore becoming more common. 

This podcast is the perfect opportunity to reflect and consider what behaviour change means to you and your practice.